Posted in | News | Nanobusiness

Nanosonics Commences Production And Sales of Trophon EPR

Nanosonics Limited (ASX:NAN) is pleased to announce that it has commenced production and commercial sale of its breakthrough Trophon(TM) EPR ultrasound probe disinfector system, through distribution partners in New Zealand and Australia.

Shipments, comprising Trophon EPR systems and NanoNebulant(TM) consumables, have been allocated to fulfil purchase orders already placed on the distribution partners by their customers, clinical end-users of the products.

The Company has undertaken a full sales launch to ultrasound professionals, including trade advertising and sales presentations to key opinion leaders and clinics throughout Australasia. Sales demand is being driven by the unique value proposition provided by the Trophon EPR system in the medical ultrasound market. A contributing factor to this demand is the greater awareness and vigilance of mandated legislation, regulatory requirements and the significant OH&S issues facing hospital and clinic staff.

The Trophon EPR is now being included in tenders submitted by the Original Equipment Manufacturers (OEMs). Further, the Company has been advised that the Trophon EPR has been incorporated as a condition in several new Government tenders, both in Australia and internationally.

Nanosonics has commenced a broad range of pre-launch activities in Europe, with first shipments expected in the next quarter of 2009. The Company has established a strong dealer network throughout Europe, each of whom has committed to commercial purchases of the Trophon EPR system to support the European launch.

It is expected that the Trophon EPR system will be launched in the near term into certain key markets in Asia, where the regulatory requirements for sale have already been met.

Sales demand in this region is being influenced by the recent Guidelines issued by the US Centre for Disease Control (CDC), Nanosonics now has substantial technical resources available to pursue additional commercial products based upon its novel NanoNebulant platform. Prototyping is now well advanced for several new devices which address substantial global market needs.

The Company is in commercial discussions with both equipment manufacturers and other potential strategic partners, with a view to bringing devices to market where the Company's technology can deliver automated, safe, effective and environmentally sound solutions to the growing range of markets in healthcare and beyond.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Nanosonics. (2019, February 14). Nanosonics Commences Production And Sales of Trophon EPR. AZoNano. Retrieved on September 16, 2021 from

  • MLA

    Nanosonics. "Nanosonics Commences Production And Sales of Trophon EPR". AZoNano. 16 September 2021. <>.

  • Chicago

    Nanosonics. "Nanosonics Commences Production And Sales of Trophon EPR". AZoNano. (accessed September 16, 2021).

  • Harvard

    Nanosonics. 2019. Nanosonics Commences Production And Sales of Trophon EPR. AZoNano, viewed 16 September 2021,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback